| 11/05/2025 | TEVA | Teva Pharmaceutical Indus | FY | 2025 | $2.55 | $2.65 | $2.53 | $16.80B | $17.00B | $16.86B | Get Alert |
| 07/30/2025 | TEVA | Teva Pharmaceutical Indus | FY | 2025 | $2.50 | $2.60 | $2.50 | $16.80B | $17.20B | $16.97B | Get Alert |
| 05/07/2025 | TEVA | Teva Pharmaceutical Indus | FY | 2025 | $2.45 | $2.65 | $2.56 | $16.80B | $17.20B | $17.24B | Get Alert |
| 03/27/2025 | TEVA | Teva Pharmaceutical Indus | FY | 2025 | $2.35 | $2.65 | $2.54 | $16.80B | $17.40B | $17.14B | Get Alert |
| 03/27/2025 | TEVA | Teva Pharmaceutical Indus | Q1 | 2025 | $0.52 | $0.52 | $0.48 | $3.99B | $3.99B | $3.98B | Get Alert |
| 01/29/2025 | TEVA | Teva Pharmaceutical Indus | FY | 2025 | $2.35 | $2.65 | $2.78 | $16.80B | $17.40B | $17.09B | Get Alert |
| 11/06/2024 | TEVA | Teva Pharmaceutical Indus | FY | 2024 | $2.40 | $2.50 | $2.45 | $16.10B | $16.50B | $16.26B | Get Alert |
| 07/31/2024 | TEVA | Teva Pharmaceutical Indus | FY | 2024 | $2.30 | $2.50 | $2.34 | $16.00B | $16.40B | $16.01B | Get Alert |
| 05/08/2024 | TEVA | Teva Pharmaceutical Indus | FY | 2024 | $2.20 | $2.50 | $2.41 | $15.70B | $16.30B | $15.86B | Get Alert |
| 01/31/2024 | TEVA | Teva Pharmaceutical Indus | FY | 2024 | $2.20 | $2.50 | $2.42 | $15.70B | $16.30B | $15.57B | Get Alert |
| 11/08/2023 | TEVA | Teva Pharmaceutical Indus | FY | 2023 | $2.25 | $2.55 | $2.28 | $15.10B | $15.50B | $15.14B | Get Alert |
| 08/02/2023 | TEVA | Teva Pharmaceutical Indus | FY | 2023 | $2.25 | $2.55 | $2.27 | $15.00B | $15.40B | $15.02B | Get Alert |
| 05/10/2023 | TEVA | Teva Pharmaceutical Indus | FY | 2023 | $2.25 | $2.55 | $2.40 | $14.80B | $15.40B | $15.06B | Get Alert |
| 02/08/2023 | TEVA | Teva Pharmaceutical Indus | FY | 2023 | $2.25 | $2.55 | $2.52 | $14.80B | $15.40B | $15.23B | Get Alert |
| 11/03/2022 | TEVA | Teva Pharmaceutical Indus | FY | 2022 | $2.40 | $2.60 | $2.50 | $14.80B | $15.40B | $15.46B | Get Alert |
| 07/26/2022 | TEVA | Teva Pharmaceutical Indus | FY | 2022 | $2.40 | $2.60 | — | $15.00B | $15.60B | $15.67B | Get Alert |
| 05/03/2022 | TEVA | Teva Pharmaceutical Indus | FY | 2022 | $2.40 | $2.60 | $2.51 | $15.40B | $16.00B | $15.97B | Get Alert |
| 02/09/2022 | TEVA | Teva Pharmaceutical Indus | FY | 2022 | $2.40 | $2.60 | $2.64 | $15.60B | $16.20B | $16.32B | Get Alert |
